Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

REGENXBIO Inc. - Common Stock (NQ:RGNX)

6.760 -0.390 (-5.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 943,623
Open 7.180
Bid (Size) 6.600 (5)
Ask (Size) 7.980 (1)
Prev. Close 7.150
Today's Range 6.609 - 7.180
52wk Range 5.620 - 21.57
Shares Outstanding 43,466,186
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's after hours session
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga

Performance

YTD
-14.0%
-14.0%
1 Month
+14.2%
+14.2%
3 Month
-6.5%
-6.5%
6 Month
-35.6%
-35.6%
1 Year
-68.6%
-68.6%

More News

Read More
Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial
Via Benzinga
Signet Jewelers, BGM Group, StoneCo, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
A Glimpse Into The Expert Outlook On Regenxbio Through 7 Analysts
Via Benzinga
Regenxbio Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Friday
Via Benzinga
A Glimpse Into The Expert Outlook On Regenxbio Through 5 Analysts
Via Benzinga
Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Where Regenxbio Stands With Analysts
Via Benzinga
5 Analysts Have This To Say About Regenxbio
Via Benzinga
What 4 Analyst Ratings Have To Say About Regenxbio
Via Benzinga
Assessing Regenxbio: Insights From 5 Financial Analysts
Via Benzinga
Earnings Scheduled For March 13, 2025
Via Benzinga
Where Regenxbio Stands With Analysts
Via Benzinga
Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Workday, Apollo Global To Join S&P 500 Index In Quarterly Balance
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
What's Going On With REGENXBIO Shares Monday?
Via Benzinga
Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
Via FinancialNewsMedia
Exposures COVID-19
7 Biotech Stocks to Buy for Their Game-Changing Potential
Via InvestorPlace
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
From FN Media Group LLC
Via GlobeNewswire
Why Is Clearside Biomedical Stock Gaining Today?
Via Benzinga

Frequently Asked Questions

Is REGENXBIO Inc. - Common Stock publicly traded?
Yes, REGENXBIO Inc. - Common Stock is publicly traded.
What exchange does REGENXBIO Inc. - Common Stock trade on?
REGENXBIO Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for REGENXBIO Inc. - Common Stock?
The ticker symbol for REGENXBIO Inc. - Common Stock is RGNX on the Nasdaq Stock Market
What is the current price of REGENXBIO Inc. - Common Stock?
The current price of REGENXBIO Inc. - Common Stock is 6.760
When was REGENXBIO Inc. - Common Stock last traded?
The last trade of REGENXBIO Inc. - Common Stock was at 04/01/25 04:00 PM ET
What is the market capitalization of REGENXBIO Inc. - Common Stock?
The market capitalization of REGENXBIO Inc. - Common Stock is 293.83M
How many shares of REGENXBIO Inc. - Common Stock are outstanding?
REGENXBIO Inc. - Common Stock has 294M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.